RECRUITINGOBSERVATIONAL
Hamburg AoRtic Valve cOhoRt
Clinical Cohort Study - Hamburg AoRtic Valve cOhoRt
About This Trial
The primary aim of the study is to identify the optimal treatment modality for patients with aortic valve disease, incorporating the individual patient's risk profile and anticipated clinical outcomes. This includes the association of demographic factors, procedural data and biomarkers with clinical outcome in a prospective fashion.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients with clinically relevant aortic valve disease (aortic valve stenosis, aortic regurgitation, degenerated aortic valve prosthesis)
- Written willing to sign a consent form
Who Should NOT Join This Trial:
- Insufficient knowledge of the German language (able to understand and write the German language)
- Physical or psychological incapability to take part in the investigation
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients with clinically relevant aortic valve disease (aortic valve stenosis, aortic regurgitation, degenerated aortic valve prosthesis)
* Written informed consent
Exclusion Criteria:
* Insufficient knowledge of the German language (able to understand and write the German language)
* Physical or psychological incapability to take part in the investigation
Locations (1)
Universitäres Herz- und Gefäßzentrum
Hamburg, Germany